Amgen Ventures
Amgen Ventures was formed in 2004 to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics. Amgen Ventures reflects Amgen’s commitment to helping patients through cutting-edge science and its desire to transform science through innovation.  As an important component of Amgen’s overall outreach strategy, Amgen Ventures invests in early-stage biotechnology companies focused on discovering and developing human therapeutics. The fund offers early-stage companies access to Amgen’s extensive capabilities while providing Amgen with insight into external research innovations that may pave the way for future collaborations.

HealthCare Ventures (HCV)
HCV is one of the world's largest venture capital firms specializing in health care, making investments in early stage and emerging growth companies that have the potential for exceptional growth. The firm has successfully raised and managed eight funds totaling $1.6 billion during the past 22 years. Notable HealthCare Ventures investments include public companies such as Advancis Pharmaceutical Corp., Critical Therapeutics, Dendreon Pharmaceuticals, Diversa Corp., Human Genome Sciences, LeukoSite, MedImmune, NitroMed, OraSure, Replidyne, Inc., Shire Pharmaceuticals, and Vicuron Pharmaceuticals.

Kammerer Associates, LLC
Kammerer Associates is a private investment firm that selectively invests in high quality young companies.

Latterell Venture Partners (LVP)
Latterell Venture Partners invests in early stage health care companies with innovative technologies, large market opportunities, and passionate entrepreneurs. LVP offers a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable it to help entrepreneurs create highly successful new startups. LVP is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns for its limited partners while providing major new disease treatments to help patients worldwide. LVP has more than $300 million of committed capital to help startup ventures achieve success.

Novitas Capital
Founded in 1997, Novitas Capital mines innovation and opportunities where investment for seed, start-up and early stage technology and life sciences ventures is scarce. Novitas discovers companies at their earliest stages, thoroughly vets them and, upon typically leading investment rounds, takes an active role in facilitating their success. Based in Wayne, Pennsylvania, with offices in Pittsburgh, Pennsylvania; Allendale, New Jersey; and Morgantown, West Virginia, Novitas currently has approximately 30 active portfolio companies and $237.5 million under management across three venture capital funds.

Quaker BioVentures
Quaker BioVentures is a venture capital firm investing only in life science companies. The firm leads investments across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development, from early stage businesses to public companies. The firm was formed in 2003 and is currently investing Quaker BioVentures II, which was formed in 2007. Quaker BioVentures manages over $500M in committed capital.

Vertical Group
The Vertical Group is a venture capital firm that is focused on the fields of medical technology and biotechnology. For more than 30 years, the principals of The Vertical Group have been founders, early stage investors, major shareholders, and executives of many of the medical technology industry's most successful companies. The Vertical Group manages private partnerships with a "vertical" range of investments including: early and late venture stage companies; private operating companies involved in buy-out or corporate spin-off transactions; and public companies of all sizes. The Vertical Group is the successor to the venture capital division of F. Eberstadt & Co., and has been an independent firm since 1988.